stockrowCencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
Follow COR
Alert me
Cencora, Inc. (COR) Return on assets
Cencora, Inc.'s return on assets over the twelve months to 30 September 2026 was 4.26%. Over the past ten years it has ranged from −8.17% (fiscal 2020) to 4.64% (fiscal 2016); the current reading is higher than 83% of that period. That is above the Medical Distribution industry median of −1.95% and above the Healthcare sector median of −29.5%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2026 | 4.26% | 2.10 |
| FY2025 | 2.16% | (0.17) |
| FY2024 | 2.33% | (0.60) |
| FY2023 | 2.93% | (0.05) |
| FY2022 | 2.98% | (0.05) |
| FY2021 | 3.03% | 11.20 |
| FY2020 | −8.17% | (10.40) |
| FY2019 | 2.23% | (2.31) |
| FY2018 | 4.54% | 3.48 |
| FY2017 | 1.06% | (3.58) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| MCK McKesson Corporation compare | 5.33% |
| COR Cencora, Inc. | 4.26% |
| HSIC Henry Schein, Inc. compare | 3.72% |
| CAH Cardinal Health, Inc. compare | 3.17% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| YI 111, Inc. Sponsored ADR compare | −3.89% |
| ACH Accendra Health, Inc. compare | −9.65% |
| COSM Cosmos Health Inc. compare | −39.6% |
| FOCL FocalTherics compare | −50.3% |
| Medical Distribution industry median | −1.95% |
| Healthcare sector median | −29.5% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement